Joint Formulary & PAD

Repaglinide - Diabetes Mellitus

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

PAD Profile

ChemicalSubstance :
Repaglinide
Indication :
Diabetes Mellitus
Group Name :
Keywords :
Meglitinide, Blood Glucose lowering drug, Type II
Brand Names Include :
Enyglid, Prandin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4

Other Indications

Below are listed other indications that Repaglinide is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Diabetes Mellitus.

Committee Recommendations (1)

Repaglinide is a clinically effective and cost effective alternative for monotherapy, however is not licensed with non-metformin combinations at first intensification. No recommendation is made in the guidelines below, as there is very little usage in Surrey.